Pharmacoepidemiology of Clinically Relevant Hypothyroidism and Hypertension From Sunitinib and Sorafenib

Oncologist - United States
doi 10.1634/theoncologist.2016-0233
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Hypothyroidism Side Effect in Patients Treated With Sunitinib or Sorafenib: Clinical and Structural Analyses

PLoS ONE
Multidisciplinary
2016English

Clinically Relevant Findings.

Journal of Clinical Investigation
Medicine
1997English

Hypothyroidism and Hypertension: Fact or Myth?

The Lancet
Medicine
2018English

Thyroid Dysfunction in Patients Treated With Sunitinib or Sorafenib

Clinical Genitourinary Cancer
OncologyUrology
2012English

Clinically Relevant Biomechanics of the Knee Capsule and Ligaments

Knee Surgery, Sports Traumatology, Arthroscopy
SurgeryOrthopedicsSports MedicineSports Science
2015English

The Clinical Implications of Sunitinib-Induced Hypothyroidism: A Prospective Evaluation

British Journal of Cancer
Cancer ResearchOncology
2008English

Pharmacoepidemiology and Pharmacology

Folia Pharmacologica Japonica
Pharmacology
2012English

High-Resolution Copy Number Patterns From Clinically Relevant FFPE Material

Scientific Reports
Multidisciplinary
2019English

ABO Titers: Harmonization and Identifying Clinically Relevant ABO Antibodies

Transfusion
AllergyImmunologyHematology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy